RND pump inhibition: in-silico and in-vitro study by Eugenol on clinical strain of E. coli and P. aeruginosa

EE Ashtiani, Z Gholizadeh Siahmazgi, M Mirpour… - In Silico …, 2023 - Springer
Abstract Multidrug-resistant (MDR) gram-negative bacteria pose significant challenges to the
public health. Various factors are involved in the development and spread of MDR strains …

Screening of natural products and derivatives for the identification of RND efflux pump inhibitors

D Choudhury, A Das Talukdar, P Chetia… - … Chemistry & High …, 2016 - ingentaconnect.com
Aim and objective: Overexpression of efflux pumps belonging to the Resistance Nodulation
cell Division (RND) family is the most important intrinsic resistance mechanism of …

[PDF][PDF] Role of a novel terpenoid as efflux inhibitor in targeting the efflux protein (mexa) of multidrug resistant, Pseudomonas aeruginosa

R Jasmine, BN Selvakumar, S Aishwarya - Int J Pharm Sci Res, 2012 - Citeseer
Pseudomonas aeruginosa, is one among the few drug resistant organisms causing Urinary
Tract Infection. Most strains of Pseudomonas aeruginosa are significantly more resistant …

Exploring imidazo[4,5-g]quinoline-4,9-dione derivatives as Acinetobacter baumannii efflux pump inhibitor: an in silico approach

P Brindangnanam, K Ashokkumar… - Journal of …, 2023 - Taylor & Francis
Antimicrobial resistance (AMR) is fast becoming a medical crisis affecting the entire global
population. World Health Organization (WHO) statistics show that globally 0.7 million people …

[PDF][PDF] Identification of inhibitors for RND efflux pump of Pseudomonas aeruginosa using structurebased pharmacophore modeling approach

V Aparna, N Mohanalakshmi… - … Journal of Pharmacy …, 2014 - researchgate.net
ABSTRACT Objective: Multidrug resistant Pseudomonas aeruginosa possess multiple ways
of resistance with the expression of efflux pump proteins as one of the major mechanisms …

In silico screening and in vitro validation of phytocompounds as multidrug efflux pump inhibitor against E. coli

Samreen, FA Qais, I Ahmad - Journal of Biomolecular Structure and …, 2023 - Taylor & Francis
Multiple drug resistance (MDR) in bacteria has increased globally in recent times. This has
reduced the efficacy of antibiotics and increasing the rate of therapeutic failure. Targeting …

Identification of Potential Therapeutics of Mentha Essential Oil Content as Antibacterial MDR Agents against AcrAB-TolC Multidrug Efflux Pump from Escherichia coli …

R Alenazy - Life, 2024 - mdpi.com
Multidrug-resistant bacterial pathogens, such as E. coli, represent a major human health
threat. Due to the critical need to overcome this dilemma, since the drug efflux pump has a …

In silico and Molecular Docking Studies of Black Pepper Phyto-constituents against EmrD Efflux Pump of E. coli.

P Dongre, R Bhambar… - Indian Journal of …, 2022 - search.ebscohost.com
Multidrug resistance (MDR) bacterial infection is the next pandemic waiting behind the
COVID-19 with annual mortality rate 700000 worldwide. Among the MDR bacteria …

In Silico Screening and Experimental Validation of Novel MexAB–OprM Efflux Pump Inhibitors of Pseudomonas aeruginosa

S Abdelmalek, M Hajar, L Salah… - Microbial Drug …, 2024 - liebertpub.com
The emergence of multidrug-resistant Pseudomonas aeruginosa possesses a significant
public health concern. Constitutively expressed MexAB–OprM efflux pumps in P. aeruginosa …

[HTML][HTML] The effects of berberine and palmatine on efflux pumps inhibition with different gene patterns in Pseudomonas aeruginosa isolated from burn infections

SS Aghayan, HK Mogadam, M Fazli… - Avicenna journal of …, 2017 - ncbi.nlm.nih.gov
Background: Related Multidrug Resistance (MDR) to efflux pumps is a significant problem in
treating infections caused by Pseudomonas aeruginosa (P. aeruginosa). Plant compounds …